Eli Lilly and Company (LLY)
USD 764.71
(-1.79%)
USD 764.71
(-1.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 34.12 Billion | 28.54 Billion | 28.31 Billion | 24.53 Billion | 22.31 Billion | 21.49 Billion |
| Cost of Revenue | 7.08 Billion | 6.62 Billion | 7.31 Billion | 5.48 Billion | 4.72 Billion | 4.68 Billion |
| Gross Profit | 27.04 Billion | 21.91 Billion | 21 Billion | 19.05 Billion | 17.59 Billion | 16.81 Billion |
| Operating Expenses | 16.71 Billion | 13.63 Billion | 13.45 Billion | 12.2 Billion | 11.8 Billion | 11.02 Billion |
| Selling, General and Administrative Expenses | 6.94 Billion | 6.44 Billion | 6.43 Billion | 6.12 Billion | 6.21 Billion | 5.97 Billion |
| Research and Development Expenses | 9.31 Billion | 7.19 Billion | 7.02 Billion | 6.08 Billion | 5.59 Billion | 5.05 Billion |
| Other Expenses | - | -52.1 Million | 112.8 Million | 1.49 Billion | 611.8 Million | 145.6 Million |
| Cost and Expenses | 23.79 Billion | 20.26 Billion | 20.77 Billion | 17.69 Billion | 16.53 Billion | 15.7 Billion |
| Operating Income | 10.32 Billion | 7.12 Billion | 6.35 Billion | 6.05 Billion | 4.97 Billion | 6.18 Billion |
| Interest Expense | 485.9 Million | 331.6 Million | 339.8 Million | 359.6 Million | 400.6 Million | 272.1 Million |
| Income Tax Expense | 1.31 Billion | 561.6 Million | 573.8 Million | 1.03 Billion | 628 Million | 529.5 Million |
| Earnings before Tax | 6.55 Billion | 6.8 Billion | 6.15 Billion | 7.22 Billion | 5.26 Billion | 3.68 Billion |
| Net Income | 5.24 Billion | 6.24 Billion | 5.58 Billion | 6.19 Billion | 4.63 Billion | 3.23 Billion |
| Earnings Per Share Basic | 5.80 | 6.93 | 6.15 | 6.82 | 4.98 | 3.14 |
| Earnings Per Share Diluted | 5.80 | 6.90 | 6.12 | 6.79 | 4.96 | 3.13 |
| Weighted Average Shares Outstanding | 903.51 Million | 901.73 Million | 906.96 Million | 907.63 Million | 931.05 Million | 1.02 Billion |
| Weighted Average Shares Outstanding (Diluted) | 903.28 Million | 904.61 Million | 911.68 Million | 912.5 Million | 935.68 Million | 1.03 Billion |
| Gross Margin | 0.79 | 0.77 | 0.74 | 0.78 | 0.79 | 0.78 |
| EBIT Margin | 0.25 | 0.33 | 0.31 | 0.31 | 0.30 | 0.45 |
| Profit Margin | 0.15 | 0.22 | 0.20 | 0.25 | 0.21 | 0.15 |
| EBITDA | 8.56 Billion | 8.66 Billion | 8.04 Billion | 8.91 Billion | 6.89 Billion | 5.53 Billion |
| Earnings Before Tax Margin | 0.30 | 0.25 | 0.22 | 0.25 | 0.22 | 0.29 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 11.43 Billion | 11.3 Billion | 8.76 Billion | 34.12 Billion | 9.35 Billion | 9.49 Billion |
| Cost of Revenue | 2.17 Billion | 2.17 Billion | 1.53 Billion | 6.57 Billion | 1.65 Billion | 1.86 Billion |
| Gross Profit | 9.26 Billion | 9.13 Billion | 7.23 Billion | 27.54 Billion | 7.69 Billion | 7.63 Billion |
| Operating Expenses | 4.83 Billion | 4.82 Billion | 4.61 Billion | 17.22 Billion | 4.61 Billion | 4.21 Billion |
| Selling, General and Administrative Expenses | 2.09 Billion | 2.11 Billion | 1.95 Billion | - | 1.92 Billion | 1.8 Billion |
| Research and Development Expenses | 2.73 Billion | 2.71 Billion | 2.52 Billion | - | 2.56 Billion | 2.4 Billion |
| Other Expenses | -139.4 Million | -7.8 Million | -139.1 Million | -506.2 Million | -129 Million | 52.5 Million |
| Cost and Expenses | 7 Billion | 6.99 Billion | 6.14 Billion | 23.79 Billion | 6.27 Billion | 6.07 Billion |
| Operating Income | 4.43 Billion | 4.3 Billion | 2.61 Billion | 10.32 Billion | 3.07 Billion | 450.4 Million |
| Interest Expense | 192.7 Million | 183.6 Million | 133.8 Million | 312.3 Million | 93.7 Million | 124.6 Million |
| Income Tax Expense | 618.1 Million | 550.2 Million | 293.2 Million | 1.31 Billion | 319.2 Million | 484.6 Million |
| Earnings before Tax | 1.58 Billion | 3.51 Billion | 2.53 Billion | 6.55 Billion | 2.5 Billion | 427.2 Million |
| Net Income | 970.3 Million | 2.96 Billion | 2.24 Billion | 5.24 Billion | 2.18 Billion | -57.4 Million |
| Earnings Per Share Basic | 1.08 | 3.29 | 2.49 | - | 2.31 | -0.06 |
| Earnings Per Share Diluted | 1.07 | 3.28 | 2.48 | - | 2.31 | -0.06 |
| Weighted Average Shares Outstanding | 901 Million | 900.9 Million | 900.8 Million | 900.18 Million | 949.37 Million | 899.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 905 Million | 904.2 Million | 903.8 Million | 903.28 Million | 949.37 Million | 899.8 Million |
| Gross Margin | 0.81 | 0.81 | 0.82 | 0.81 | 0.82 | 0.80 |
| EBIT Margin | 0.20 | 0.42 | 0.37 | - | 0.39 | 0.67 |
| Profit Margin | 0.08 | 0.26 | 0.26 | 0.15 | 0.23 | -0.01 |
| EBITDA | 2.24 Billion | 4.71 Billion | 3.21 Billion | - | 3.6 Billion | 6.4 Billion |
| Earnings Before Tax Margin | 0.39 | 0.38 | 0.30 | 0.30 | 0.33 | 0.05 |
601901
2314
ELISA
HNLGY
ACRU
0R38